Faculty of Health and Life Sciences, Women's and Children's Health, Liverpool Health Partners, University of Liverpool, Liverpool, UK.
Department of Women's and Children's Health, Institute in the Park, University of Liverpool, Alder Hey NHS Children's Foundation Trust, Liverpool, UK.
Ther Innov Regul Sci. 2022 Nov;56(6):948-963. doi: 10.1007/s43441-022-00382-4. Epub 2022 Feb 19.
Listening to, and acting on, the voices of children and families during clinical research and innovation is fundamental to ensuring enhanced pediatric health care, medicines development, and technological advances. While this is often discussed as an important step in ensuring patient-centered care, involving children and families across the life cycle of clinical research is not currently routine. The pediatric research community needs to address how to meaningfully involve children and families if they are to succeed in designing clinical research that suits the needs of pediatric patients and their families. This paper describes how an international community working under the umbrella International Children's Advisory Network (iCAN) and European Young Person's Advisory Group Network (eYPAGnet) has involved children and families in the design and delivery of pediatric clinical research. It offers practical solutions through various case studies assessed against seven patient engagement quality criteria within the Patient Engagement Quality Guidance (PEQG) tool, highlighting some of the lessons learnt from involving and engaging with children and families across different stages of clinical research, including pediatric trials for drug development programs.
在临床研究和创新过程中倾听并采纳儿童和家庭的意见,对于加强儿科医疗保健、药品开发和技术进步至关重要。尽管人们经常将这一做法视为确保以患者为中心的护理的重要步骤,但在临床研究的整个生命周期中让儿童和家庭参与进来目前还不是常规做法。儿科研究界需要解决如何让儿童和家庭切实参与进来的问题,这样才能成功设计出适合儿科患者及其家庭需求的临床研究。本文介绍了在国际儿童咨询网络(iCAN)和欧洲青年咨询小组网络(eYPAGnet)的框架下开展工作的一个国际团体如何让儿童和家庭参与到儿科临床研究的设计和实施中来。本文通过根据患者参与质量指南(PEQG)工具中的 7 项患者参与质量标准评估的多个案例研究提供了切实可行的解决方案,重点介绍了在临床研究的不同阶段,包括药物开发项目的儿科试验中,让儿童和家庭参与和互动所获得的一些经验教训。